144 related articles for article (PubMed ID: 7596985)
1. Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).
Bai JP; Hsu MJ; Shier WT
Pharm Res; 1995 Apr; 12(4):513-7. PubMed ID: 7596985
[TBL] [Abstract][Full Text] [Related]
2. The presence of insulin-degrading enzyme in human ileal and colonic mucosal cells.
Bai JP; Hong HJ; Rothenberger DA; Wong WD; Buls JG
J Pharm Pharmacol; 1996 Nov; 48(11):1180-4. PubMed ID: 8961169
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of insulin-degrading enzyme along the rat intestine, in the human colon adenocarcinoma cell line (Caco-2), and in human ileum.
Chang LL; Stout LE; Wong WD; Buls JG; Rothenberger DA; Shier WT; Sorenson RL; Bai JP
J Pharm Sci; 1997 Jan; 86(1):116-9. PubMed ID: 9002470
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.
Bai JP; Chang LL
Pharm Res; 1995 Aug; 12(8):1171-5. PubMed ID: 7494830
[TBL] [Abstract][Full Text] [Related]
5. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
Yaso S
Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):289-302. PubMed ID: 3042472
[TBL] [Abstract][Full Text] [Related]
6. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.
Yfanti C; Mengele K; Gkazepis A; Weirich G; Giersig C; Kuo WL; Tang WJ; Rosner M; Schmitt M
Int J Mol Med; 2008 Oct; 22(4):421-31. PubMed ID: 18813847
[TBL] [Abstract][Full Text] [Related]
7. Investigation into the presence of insulin-degrading enzyme in cultured type II alveolar cells and the effects of enzyme inhibitors on pulmonary bioavailability of insulin in rats.
Hsu MC; Bai JP
J Pharm Pharmacol; 1998 May; 50(5):507-14. PubMed ID: 9643444
[TBL] [Abstract][Full Text] [Related]
8. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.
Authier F; Rachubinski RA; Posner BI; Bergeron JJ
J Biol Chem; 1994 Jan; 269(4):3010-6. PubMed ID: 8300632
[TBL] [Abstract][Full Text] [Related]
9. Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme.
Saric T; Seitz HJ; Pavelic K
Mol Cell Endocrinol; 1994 Dec; 106(1-2):23-9. PubMed ID: 7895911
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
Bennett RG; Hamel FG; Duckworth WC
Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
[TBL] [Abstract][Full Text] [Related]
11. Potential efficacy of Lactobacillus casei IBRC_M10711 on expression and activity of insulin degrading enzyme but not insulin degradation.
Neyazi N; Mohammadi Farsani T; Nouri Z; Ghahremani MH; Khorramizadeh MR; Tajerian R; Motevaseli E
In Vitro Cell Dev Biol Anim; 2017 Jan; 53(1):12-19. PubMed ID: 27573410
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
13. Degradation of amylin by insulin-degrading enzyme.
Bennett RG; Duckworth WC; Hamel FG
J Biol Chem; 2000 Nov; 275(47):36621-5. PubMed ID: 10973971
[TBL] [Abstract][Full Text] [Related]
14. Insulin-degrading enzyme is not secreted from cultured cells.
Song ES; Rodgers DW; Hersh LB
Sci Rep; 2018 Feb; 8(1):2335. PubMed ID: 29402917
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway.
Harada S; Smith RM; Smith JA; Jarett L
Endocrinology; 1993 Jun; 132(6):2293-8. PubMed ID: 8504733
[TBL] [Abstract][Full Text] [Related]
16. Insulin-degrading enzyme hydrolyzes ATP.
Del Carmen Camberos M; Cresto JC
Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
[TBL] [Abstract][Full Text] [Related]
17. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
Duckworth WC; Bennett RG; Hamel FG
Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
[TBL] [Abstract][Full Text] [Related]
18. Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.
Sbardella D; Tundo GR; Sciandra F; Bozzi M; Gioia M; Ciaccio C; Tarantino U; Brancaccio A; Coletta M; Marini S
PLoS One; 2015; 10(7):e0132455. PubMed ID: 26186340
[TBL] [Abstract][Full Text] [Related]
19. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
[TBL] [Abstract][Full Text] [Related]
20. Degradation of relaxin family peptides by insulin-degrading enzyme.
Bennett RG; Heimann DG; Hamel FG
Ann N Y Acad Sci; 2009 Apr; 1160():38-41. PubMed ID: 19416156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
